Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Quality Index
Beijing Winsunny Pharmaceutical CO.LTD cash flow quality index. Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Quality Index of 1.41x as of December 2024. Operating cash flow of CN¥690.75 Million exceeds net income of CN¥488.67 Million, indicating high earnings quality where cash backs reported profits. See 601089 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Cash flow quality index of Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024. Historical Cash Flow Quality Index for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 601089 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Quality Index by Year (2020–2024)
Beijing Winsunny Pharmaceutical CO.LTD cash flow quality index by year from 2020 to 2024. Year-by-year earnings quality comparison for Beijing Winsunny Pharmaceutical CO.LTD. For the full cash flow conversion analysis, see Beijing Winsunny Pharmaceutical CO.LTD operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.41x | CN¥690.75 Million | CN¥488.67 Million | ▲ +24.3% |
| 2023 | 1.14x | CN¥555.90 Million | CN¥488.77 Million | ▼ -24.4% |
| 2022 | 1.50x | CN¥659.76 Million | CN¥438.46 Million | ▼ -9.3% |
| 2021 | 1.66x | CN¥528.02 Million | CN¥318.12 Million | ▲ +12.8% |
| 2020 | 1.47x | CN¥386.65 Million | CN¥262.71 Million | — |